Stockscreener 앱 받기
0.3073
0.13%
0.0004
시간 외 거래:
.32
0.0127
+4.13%
전일 마감가:
$0.3069
열려 있는:
$0.308
하루 거래량:
1.11M
Relative Volume:
1.30
시가총액:
$16.08M
수익:
$65.27M
순이익/손실:
$-19.15M
주가수익비율:
-0.495
EPS:
-0.6208
순현금흐름:
$-12.43M
1주 성능:
-13.44%
1개월 성능:
+2.43%
6개월 성능:
-57.91%
1년 성능:
-28.44%
1일 변동 폭
$0.297
$0.3367
1주일 범위
$0.297
$0.3662
52주 변동 폭
$0.2805
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3073 | 16.06M | 65.27M | -19.15M | -12.43M | -0.6208 |
MCK
Mckesson Corp
|
734.69 | 87.17B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
260.93 | 50.53B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
182.56 | 42.74B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
69.35 | 7.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.115 | 1.81B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health stock (US22143K1016): Fort18 launch targets $3.2M revenue boost - AD HOC NEWS
Cosmos Health withdraws SEC registration statement - Investing.com
Cosmos Health withdraws SEC registration statement By Investing.com - Investing.com Canada
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - Palestineherald.com
Cosmos Health scraps public offering, pulls SEC registration - Stock Titan
[RW] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - ACCESS Newswire
Men's stamina supplement Fort18 targets $3.2M U.S. sales - Stock Titan
Cosmos Health Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
COSM introduces new product for sexual health - MSN
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - ACCESS Newswire
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Quantisnow
COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Number of shareholders of Cosmos Health Inc. – NASDAQ:COSM - TradingView
Cosmos Health launches Fort18 men’s wellness supplement in U.S. By Investing.com - Investing.com Australia
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com UK
Cosmos Health Introduces Fort18 in the United StatesA Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness - ACCESS Newswire
Cosmos Health enters men's wellness as U.S. market heads to $1.93B - Stock Titan
Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN
Cosmos Health (COSM) Projects Significant Revenue Growth with Cu - GuruFocus
Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue - Investing.com Australia
Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue By Investing.com - Investing.com South Africa
Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - ACCESS Newswire
A turmeric supplement is central to Cosmos Health's $2.5M U.S. sales bet - Stock Titan
Cosmos Health Continues US Expansion with Q2 Launch of Cur18a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - ACCESS Newswire
Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment - Stock Titan
Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Produ - Palestineherald.com
73.5M Cosmos Health shares registered for resale (NASDAQ: COSM) - Stock Titan
Cosmos Health (COSM) Year-Ahead Outlook | Q4 2025: Below ExpectationsAcquisition - Xã Vĩnh Công
Is Cosmos Health (COSM) stock still a good play today | Q4 2025: Profit DisappointsReal-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Cosmos Health (COSM) Stock: Consolidation Phase Insight (Smart Money Flows) 2026-04-22Quantitative Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Cosmos Health Inc.: Cosmos Health Introduces the 18 Series in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Valid - FinanzNachrichten.de
Cosmos Health to begin Liv18 liver supplement production in April By Investing.com - Investing.com Australia
COSM earnings show rapid revenue growth - MSN
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.44%
5.20%
자본화:
|
볼륨(24시간):